Clinical implications of enteroadherent escherichia coli

被引:22
作者
Margarita M. P. Arenas-Hernández
Ygnacio Martínez-Laguna
Alfredo G. Torres
机构
[1] Posgrado en Microbiología, Centro de Investigaciones en Ciencias Microbiológicas, B. Universidad Autónoma de Puebla, Puebla
[2] Department of Microbiology and Immunology, Center for Vaccine Development, University of Texas Medical Branch, Galveston
基金
美国国家卫生研究院;
关键词
Adherence; Diarrhea; Enteroaggregative E. coli; Enteropathogenic E. coli; Enterotoxigenic E. coli; Pathogenic Escherichia coli; Virulence;
D O I
10.1007/s11894-012-0277-1
中图分类号
学科分类号
摘要
Pathogenic Escherichia coli that colonize the small intestine primarily cause gastrointestinal illness in infants and travelers. The main categories of pathogenic E. coli that colonize the epithelial lining of the small intestine are enterotoxigenic E. coli, enteropathogenic E. coli, and enteroaggregative E. coli. These organisms accomplish their pathogenic process by a complex, coordinated multistage strategy, including nonintimate adherence mediated by various adhesins. These so called 'enteroadherent E. coli' categories subsequently produce toxins or effector proteins that are either secreted to the milieu or injected to the host cell. Finally, destruction of the intestinal microvilli results from the intimate adherence or the toxic effect exerted over the epithelia, resulting in water secretion and diarrhea. In this review, we summarize the current state of knowledge regarding these enteroadherent E. coli strains and the present clinical understanding of how these organisms colonize the human intestine and cause disease. © Springer Science+Business Media, LLC 2012.
引用
收藏
页码:386 / 394
页数:8
相关论文
共 71 条
  • [1] Torres A.G., Zhou X., Kaper J.B., Adherence of diarrheagenic Escherichia coli strains to epithelial cells, Infect Immun., 73, pp. 18-29, (2005)
  • [2] Kaper J.B., Nataro J.P., Mobley H.L.T., Pathogenic Escherichia coli, Nat Rev Microbiol., 2, pp. 123-140, (2004)
  • [3] Future directions for research on enterotoxigenic escherichia coli vaccines for developing countries, Wkly Epidemiol Rec., 81, pp. 97-104, (2006)
  • [4] Wang M., Szucs T.D., Steffen R., Economic aspects of travelers' diarrhea, J Travel Med., 15, pp. 110-118, (2008)
  • [5] Qadri F., Saha A., Ahmed T., Al Tarique A., Begum Y.A., Svennerholm A.M., Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh, Infect Immun., 75, pp. 3961-3968, (2007)
  • [6] Fleckenstein J.M., Hardwidge P.R., Munson G.P., Rasko D.A., Sommerfelt H., Steinsland H., Molecular mechanisms of enterotoxigenic Escherichia coli infection, Microbes Infect., 12, pp. 89-98, (2010)
  • [7] Qadri F., Svennerholm A.M., Faruque A.S., Sack R.B., Enterotoxigenic Escherichia coli in developing countries: Epidemiology, microbiology, clinical features, treatment, and prevention, Clin Microbiol Rev., 18, pp. 465-483, (2005)
  • [8] Svennerholm A.M., Tobias J., Vaccines against enterotoxigenic Escherichia coli, Expert Rev Vaccines., 7, pp. 795-804, (2008)
  • [9] Gaastra W., Svennerholm A.M., Colonization factors of human enterotoxigenic Escherichia coli (ETEC, Trends Microbiol., 4, pp. 444-452, (1996)
  • [10] Turner S.M., Scott-Tucker A., Cooper L.M., Henderson I.R., Weapons of mass destruction: Virulence factors of the global killer enterotoxigenic Escherichia coli, FEMS Microbiol Lett., 263, pp. 10-20, (2006)